In silico development and validation of a novel six-gene-derived signature in hepatocellular carcinoma
Collectively, a unique PMRG-based signature effectively predicts prognosis in HCC patients and provides valuable insights into chemotherapy and immunotherapy strategies for these individuals.
Authors
- Chunhui Rao
- Huize Liu (ORCID: https://orcid.org/0000-0002-8662-7757)
- Jing He (ORCID: https://orcid.org/0000-0002-1954-2892)
- Weijian Chu
- Binbin Li (ORCID: https://orcid.org/0000-0002-8572-8003)
Institutions
- Zhejiang Chinese Medical University (CN)
Publication Details
- Journal
- Translational Cancer Research
- Published
- 2025-05-01
- DOI
- https://doi.org/10.21037/tcr-2024-2621
- Primary Topic
- Hepatocellular Carcinoma Treatment and Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00